Immunochemistry Services

Immunochemistry, or large molecule bioanalysis, is necessary to gain data on product efficacy, safety, disease state or mechanism of action, which will allow you to make informed and important decisions during biologic drug development.

Our immunochemistry experts provide this support through immunoassays, ligand binding assays supporting toxicokinetics (TK) and pharmacokinetics (PK) studies, immunogenicity, and biomarker studies. In support of clinical and preclinical studies, our scientists have extensive experience developing, validating, and implementing quantitative or qualitative Good Laboratory Practice (GLP) / non-GLP immunoassays.

Our technology and industry-leading immunochemistry expertise include developing and validating proprietary assays, implementing, and validating existing methods, optimizing methods then validating, and also validating existing immunoassay kits (Simoa, ELISA and ECL platforms).

With almost 30 years’ experience in large molecule bioanalysis, our experts are thought leaders in the global immunochemistry community with a strong knowledge of regulatory guidance and scientific background. Our GLP compliant laboratory in Manchester, UK, is equipped with the latest technology for immunoassay development such as quantitative ligand or receptor binding assays or immunoassays for use in pharmacokinetic (PK) and toxicokinetic (TK) studies. Our lab and scientists regularly work with clients from all around the world on a range of product types, including monoclonal antibodies, antibodies-drug conjugates, growth factors, hormones, and cytokines. 

Immunochemistry Lab Services

• Immunoassays
• Biomarker Assays
• Cell-Based Neutralization Assays
• Immunogenicity Assays
• Ligand-Binding Assays